342 related articles for article (PubMed ID: 32264897)
1. Acute respiratory distress syndrome subphenotypes and therapy responsive traits among preclinical models: protocol for a systematic review and meta-analysis.
Carla A; Pereira B; Boukail H; Audard J; Pinol-Domenech N; De Carvalho M; Blondonnet R; Zhai R; Morand D; Lambert C; Sapin V; Ware LB; Calfee CS; Bastarache JA; Laffey JG; Juffermans NP; Bos LD; Artigas A; Rocco PRM; Matthay MA; McAuley DF; Constantin JM; Jabaudon M;
Respir Res; 2020 Apr; 21(1):81. PubMed ID: 32264897
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of mesenchymal stromal cells in preclinical models of acute lung injury: a systematic review protocol.
Lalu MM; Moher D; Marshall J; Fergusson D; Mei SH; Macleod M; Griffin G; Turgeon AF; Rudnicki M; Fishman J; Avey MT; Skidmore B; Grimshaw JM; Stewart DJ; Singh K; McIntyre L;
Syst Rev; 2014 May; 3():48. PubMed ID: 24887266
[TBL] [Abstract][Full Text] [Related]
3. Biological Subphenotypes of Acute Respiratory Distress Syndrome Show Prognostic Enrichment in Mechanically Ventilated Patients without Acute Respiratory Distress Syndrome.
Heijnen NFL; Hagens LA; Smit MR; Cremer OL; Ong DSY; van der Poll T; van Vught LA; Scicluna BP; Schnabel RM; van der Horst ICC; Schultz MJ; Bergmans DCJJ; Bos LDJ
Am J Respir Crit Care Med; 2021 Jun; 203(12):1503-1511. PubMed ID: 33465019
[No Abstract] [Full Text] [Related]
4. Validation and utility of ARDS subphenotypes identified by machine-learning models using clinical data: an observational, multicohort, retrospective analysis.
Maddali MV; Churpek M; Pham T; Rezoagli E; Zhuo H; Zhao W; He J; Delucchi KL; Wang C; Wickersham N; McNeil JB; Jauregui A; Ke S; Vessel K; Gomez A; Hendrickson CM; Kangelaris KN; Sarma A; Leligdowicz A; Liu KD; Matthay MA; Ware LB; Laffey JG; Bellani G; Calfee CS; Sinha P;
Lancet Respir Med; 2022 Apr; 10(4):367-377. PubMed ID: 35026177
[TBL] [Abstract][Full Text] [Related]
5. Acute Respiratory Distress Syndrome Subphenotypes Respond Differently to Randomized Fluid Management Strategy.
Famous KR; Delucchi K; Ware LB; Kangelaris KN; Liu KD; Thompson BT; Calfee CS;
Am J Respir Crit Care Med; 2017 Feb; 195(3):331-338. PubMed ID: 27513822
[TBL] [Abstract][Full Text] [Related]
6. Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial.
Calfee CS; Delucchi KL; Sinha P; Matthay MA; Hackett J; Shankar-Hari M; McDowell C; Laffey JG; O'Kane CM; McAuley DF;
Lancet Respir Med; 2018 Sep; 6(9):691-698. PubMed ID: 30078618
[TBL] [Abstract][Full Text] [Related]
7. Stability of ARDS subphenotypes over time in two randomised controlled trials.
Delucchi K; Famous KR; Ware LB; Parsons PE; Thompson BT; Calfee CS;
Thorax; 2018 May; 73(5):439-445. PubMed ID: 29477989
[TBL] [Abstract][Full Text] [Related]
8. Biological subphenotypes of acute respiratory distress syndrome may not reflect differences in alveolar inflammation.
Heijnen NFL; Hagens LA; Smit MR; Schultz MJ; van der Poll T; Schnabel RM; van der Horst ICC; Dickson RP; Bergmans DCJJ; Bos LDJ;
Physiol Rep; 2021 Feb; 9(3):e14693. PubMed ID: 33547768
[TBL] [Abstract][Full Text] [Related]
9. Subphenotypes in patients with acute respiratory distress syndrome treated with high-flow oxygen.
Blot PL; Chousterman BG; Santafè M; Cartailler J; Pacheco A; Magret M; Masclans JR; Artigas A; Roca O; García-de-Acilu M
Crit Care; 2023 Nov; 27(1):419. PubMed ID: 37915062
[TBL] [Abstract][Full Text] [Related]
10. Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials.
Calfee CS; Delucchi K; Parsons PE; Thompson BT; Ware LB; Matthay MA;
Lancet Respir Med; 2014 Aug; 2(8):611-20. PubMed ID: 24853585
[TBL] [Abstract][Full Text] [Related]
11. High-frequency oscillatory ventilation versus conventional ventilation for acute respiratory distress syndrome.
Sud S; Sud M; Friedrich JO; Wunsch H; Meade MO; Ferguson ND; Adhikari NK
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD004085. PubMed ID: 27043185
[TBL] [Abstract][Full Text] [Related]
12. Rationale, study design, and analysis plan of the Alveolar Recruitment for ARDS Trial (ART): study protocol for a randomized controlled trial.
ART Investigators
Trials; 2012 Aug; 13():153. PubMed ID: 22929542
[TBL] [Abstract][Full Text] [Related]
13. Latent class analysis of ARDS subphenotypes: a secondary analysis of the statins for acutely injured lungs from sepsis (SAILS) study.
Sinha P; Delucchi KL; Thompson BT; McAuley DF; Matthay MA; Calfee CS;
Intensive Care Med; 2018 Nov; 44(11):1859-1869. PubMed ID: 30291376
[TBL] [Abstract][Full Text] [Related]
14. Latent class analysis-derived subphenotypes are generalisable to observational cohorts of acute respiratory distress syndrome: a prospective study.
Sinha P; Delucchi KL; Chen Y; Zhuo H; Abbott J; Wang C; Wickersham N; McNeil JB; Jauregui A; Ke S; Vessel K; Gomez A; Hendrickson CM; Kangelaris KN; Sarma A; Leligdowicz A; Liu KD; Matthay MA; Ware LB; Calfee CS
Thorax; 2022 Jan; 77(1):13-21. PubMed ID: 34253679
[TBL] [Abstract][Full Text] [Related]
15. Individualized positive end-expiratory pressure guided by end-expiratory lung volume in early acute respiratory distress syndrome: study protocol for the multicenter, randomized IPERPEEP trial.
Grieco DL; Maggiore SM; Bellani G; Spadaro S; Spinelli E; Tonetti T; Menga LS; Pozzi M; Battaglini D; Di Mussi R; Bruni A; De Gaetano A; Iovino CG; Brioni M; Mojoli F; Foti G; Volta CA; Pelosi P; Navalesi P; Grasso S; Ranieri VM; Antonelli M;
Trials; 2022 Jan; 23(1):63. PubMed ID: 35057852
[TBL] [Abstract][Full Text] [Related]
16. Identification of acute respiratory distress syndrome subphenotypes de novo using routine clinical data: a retrospective analysis of ARDS clinical trials.
Duggal A; Kast R; Van Ark E; Bulgarelli L; Siuba MT; Osborn J; Rey DA; Zampieri FG; Cavalcanti AB; Maia I; Paisani DM; Laranjeira LN; Serpa Neto A; Deliberato RO
BMJ Open; 2022 Jan; 12(1):e053297. PubMed ID: 34992112
[TBL] [Abstract][Full Text] [Related]
17. Partial liquid ventilation for preventing death and morbidity in adults with acute lung injury and acute respiratory distress syndrome.
Galvin IM; Steel A; Pinto R; Ferguson ND; Davies MW
Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD003707. PubMed ID: 23881653
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological agents for adults with acute respiratory distress syndrome.
Lewis SR; Pritchard MW; Thomas CM; Smith AF
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD004477. PubMed ID: 31334568
[TBL] [Abstract][Full Text] [Related]
19. Latent Class Analysis Reveals COVID-19-related Acute Respiratory Distress Syndrome Subgroups with Differential Responses to Corticosteroids.
Sinha P; Furfaro D; Cummings MJ; Abrams D; Delucchi K; Maddali MV; He J; Thompson A; Murn M; Fountain J; Rosen A; Robbins-Juarez SY; Adan MA; Satish T; Madhavan M; Gupta A; Lyashchenko AK; Agerstrand C; Yip NH; Burkart KM; Beitler JR; Baldwin MR; Calfee CS; Brodie D; O'Donnell MR
Am J Respir Crit Care Med; 2021 Dec; 204(11):1274-1285. PubMed ID: 34543591
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
